Wall Street Zen downgraded shares of BKV (NYSE:BKV – Free Report) from a sell rating to a strong sell rating in a research report sent to investors on Saturday,Wall Street Zen reports.
Other equities analysts have also recently issued research reports about the company. Truist Financial boosted their price objective on BKV from $33.00 to $34.00 and gave the company a “buy” rating in a report on Wednesday. Weiss Ratings raised BKV from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, October 8th. Susquehanna reduced their price target on BKV from $37.00 to $35.00 and set a “positive” rating for the company in a research report on Tuesday, July 21st. Barclays reduced their price target on BKV from $36.00 to $35.00 and set an “overweight” rating for the company in a research report on Tuesday, September 15th. Finally, Evercore raised BKV to a “strong-buy” rating in a report on Friday, September 18th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $33.67.
Read Our Latest Stock Analysis on BKV
BKV Trading Up 2.6%
NYSE BKV opened at $22.88 on Friday. The company has a market capitalization of $2.50 billion, a PE ratio of 8.35 and a beta of 1.13. The company has a fifty day moving average of $24.11 and a 200 day moving average of $25.87. BKV has a 1 year low of $20.08 and a 1 year high of $32.81. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.15 and a quick ratio of 1.10.
BKV (NYSE:BKV – Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.46 EPS for the quarter, beating the consensus estimate of $0.25 by $0.21. The company had revenue of $465.54 million for the quarter, compared to analyst estimates of $355.25 million. BKV had a net margin of 17.73% and a return on equity of 6.67%. Research analysts forecast that BKV will post 1.49 earnings per share for the current year.
Insider Activity at BKV
In other news, insider Lindsay B. Larrick sold 10,000 shares of the stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $26.16, for a total transaction of $261,600.00. Following the sale, the insider directly owned 83,925 shares of the company’s stock, valued at $2,195,478. This represents a 10.65% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO David Tameron sold 1,500 shares of the firm’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $25.63, for a total value of $38,445.00. Following the sale, the chief financial officer owned 57,024 shares in the company, valued at $1,461,525.12. This trade represents a 2.56% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 35,626 shares of company stock worth $901,589. 2.51% of the stock is owned by company insiders.
Hedge Funds Weigh In On BKV
Several institutional investors and hedge funds have recently modified their holdings of the business. BlackRock Inc. purchased a new position in BKV during the second quarter worth approximately $74,241,000. Cooper Creek Partners Management LLC grew its holdings in BKV by 24.7% in the first quarter. Cooper Creek Partners Management LLC now owns 2,103,230 shares of the company’s stock valued at $59,984,000 after purchasing an additional 416,281 shares during the period. William Blair Investment Management LLC acquired a new stake in BKV in the second quarter valued at approximately $32,689,000. Value Aligned Research Advisors LLC increased its position in shares of BKV by 110.5% in the second quarter. Value Aligned Research Advisors LLC now owns 679,899 shares of the company’s stock valued at $18,602,000 after buying an additional 356,848 shares in the last quarter. Finally, Bank of America Corp DE purchased a new stake in shares of BKV in the second quarter valued at approximately $16,177,000.
BKV Company Profile
BKV Corporation is an energy company focused on natural gas production and related energy-transition solutions. The company explores for, develops and produces natural gas and natural gas liquids, with operations primarily centered in major U.S. shale basins.
BKV’s activities include upstream oil and gas development, natural gas marketing and midstream services. The company also develops carbon capture, utilization and storage projects intended to reduce emissions associated with natural gas production and use, as well as renewable natural gas initiatives.
Based in Denver, Colorado, BKV serves U.S.
Recommended Stories
- Five stocks we like better than BKV
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Receive News & Ratings for BKV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BKV and related companies with MarketBeat.com's FREE daily email newsletter.
